The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris

Eur J Dermatol. 2016 Aug 1;26(4):404-5. doi: 10.1684/ejd.2016.2781.

Authors

Affiliations

¹ Department of Dermatology, University of Tokyo Graduate School of Medicine.
² Department of Neurology, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan.

PMID: 27086491
DOI: 10.1684/ejd.2016.2781

No abstract available

Publication types

Case Reports

MeSH terms

Adalimumab / adverse effects*
Adult
Anti-Inflammatory Agents / adverse effects*
Humans
Male
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced*
Psoriasis / drug therapy*

Substances

Anti-Inflammatory Agents
Adalimumab